期刊文献+

慢性乙型肝炎肝脏趋化因子CCL20表达与其组织学积分相关 被引量:1

CCL20 Expression in Liver Biopsies of CHB Patients Showed Correlation to their HAI
下载PDF
导出
摘要 目的研究慢性乙型肝炎(CHB)肝活检组织CCL20的表达与病理分级分期的关系,探讨CCL20在慢性乙肝病毒感染中的作用及意义.方法通过RT—PCR对17例正常肝脏和67例CHB活检组织的CCL20进行半定量(以看家基因GAPDH为对照),结合肝脏组织学积分研究其相关性.结果在HBV慢性感染状态下肝活检组织CCL20的表达水平呈现出个体差异,其CCL20/GAPDH为0.33±0.12,显著低于其在正常肝组织中的平均表达量0.54±0.16(P〈0.01),CCL20/GAPDH在两组之间差异有统计学显著性意义(P〈0.01),CHB患者肝脏中CCL20/GAPDH的表达水平显著降低,且与肝脏的组织学积分相关(r=0.675,P=0.023).结论HBV慢性感染状态下CCL20/GAPDH降低,CCL20的表达与肝脏组织学积分相关. Objective To investigate the roles and significance of CCL20 expression in liver biopsies of patients with CHB. Methods 67 liver biopsies tissues were used to observe the correlation between HAI of CHB and CCL20 expression. On the basis of established RT-PCR,the expression of the CCL20 in the liver biopsies were semi-quantified (CCL20/GAPDH, GAPDH was considered as housekeeping gene) and at the same time its correlation to HAl were explored. Results Expression of CCL20 in CHB patients showed difference in persons and its CCL20/GAPDH was 0. 33±0. 12,which was lower than that of control groups, which was 0. 54 ± 0. 16 (P〈0.01). That is to say,CCL20 expression in liver biopsies with CHB were decreased than that of in control group(P〈0. 01) and correlation lied in between HAI (Necrosis) and CCL20 expression in liver biopsies of CHB patients(r=0. 675,P=0. 023). Conclusion CCL20 expression was down-regulated in CHB liver biopsies and it showed correlation to HAI of patients,which may be involved in chronic HBV infection.
机构地区 解放军第
出处 《现代检验医学杂志》 CAS 2009年第2期34-36,共3页 Journal of Modern Laboratory Medicine
基金 南京军区卫生专业人才培养“122工程”资助项目.
关键词 CCL20 慢性乙型肝炎 组织学积分 降低 CC subtype ehemokine ligand 20 chronic hepatitis B HAI down-regulated
  • 相关文献

参考文献14

  • 1Ando K,Guidotti LG,Wirth S,et al. Class I-restricted eytotoxic T lymphoeytes are direetlyeytopathic for their target cells in vivo [J]. J Immunol, 1994, 152 (7) : 3245-3253.
  • 2Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis[J]. Annu Rev Immunol, 1995,13 : 29-60.
  • 3Hieshima K, Imai T, Opdenakker G, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2[J]. J Biol Chern, 1997, 272(9):5846-5853.
  • 4Crittenden M ,Gough M ,Harrington K,et al. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity [J]. Cancer Res, 2003, 63 (17) : 5505-5512.
  • 5叶巍,邵先安,郑秀娟,陈习武,储以微,熊思东.定量检测CCL20的竞争性内参照RT-PCR的建立及其初步应用[J].复旦学报(医学版),2005,32(3):359-364. 被引量:3
  • 6Knodell RG, Ishak KG, Black WC,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [J]. Hepatology, 1981,1 (5) :431-435.
  • 7Yuen MF,Ng IO,Fan ST,et al. Significance of HBV DNA levels in liver histology of HBeAg and Anti- HBe positive patients with chronic hepatitis B [J]. Am J Gastroenterol, 2004,99 (10) : 2032-2037.
  • 8邵先安,熊思东,徐薇,袁福华,李瑞斌,王勇,陈芝河,徐长江.趋化因子CCL20在慢性乙型肝炎活检组织中的表达及意义[J].中华检验医学杂志,2008,31(8):864-867. 被引量:4
  • 9Ebert LM,Mccoll SR. Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4^+ T lymphocytes [J ]. J Immunol, 2002,168 (1) :65-72.
  • 10Caux C,Vanbervliet B,Massacrier C,et al. Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function[J]. Exp Dermatol, 2002,11 (2) :135-142.

二级参考文献30

  • 1叶巍,邵先安,郑秀娟,陈习武,储以微,熊思东.定量检测CCL20的竞争性内参照RT-PCR的建立及其初步应用[J].复旦学报(医学版),2005,32(3):359-364. 被引量:3
  • 2邵先安,叶巍,郑秀娟,陈习武,储以微,熊思东.HBV感染对趋化因子CCL20表达的影响及其意义[J].中华微生物学和免疫学杂志,2005,25(5):351-356. 被引量:9
  • 3丁晓然,杨静,伯晓晨,张敏丽,陈苏红,王升启.靶向ASGPR的反义核酸与抗HBV药物联合用药的体外抗HBV作用[J].病毒学报,2006,22(1):17-21. 被引量:6
  • 4Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol, 2000, 3: 387-392.
  • 5Ando K, Guidotti LG, Wirth S, et al. Class Ⅰ-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol, 1994, 152: 3245-3253.
  • 6Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol, 1995,13: 29-60.
  • 7Hieshima K, Imai T, Opdenakker G, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem, 1997, 272: 5846-5853.
  • 8Furumoto K, Soares L, Engleman EG, et al. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest, 2004, 113: 774-783.
  • 9Crittenden M, Gough M, Harrington K, et al. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity. Cancer Res, 2003, 63: 5505-5512.
  • 10Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981,1:431-435.

共引文献5

同被引文献15

  • 1Morgan M,Keeffe EB.Diagnosis and treatment of chronic hepatitis B:2009 update[J].Minerva Gastroenterol Dietol,2009,55(1):5-22.
  • 2Yamauchi K,Akbar SM,Horiike N,et al.Increased serum levels of macrophage inflammatory protein-3alpha in chronic viral hepatitis:prognostic importance of macrophage inflammatory protein-3alpha during interferon therapy in chronic hepatitis C[J].J Viral Hepat,2002,9(3):213-220.
  • 3Yuen MF,Ng IO,Fan ST,et al.Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B[J].Am J Gastroenterol,2004,99(10):2032-2037.
  • 4Chan DI,Hunter HN,Tack BF,et al.Human macro-phage inflammatory protein 3alpha:protein and peptide nuclear magnetic resonance solution structures,dimerization,dynamics,and anti-infective properties[J].Antimicrob Agents Chemother,2008,52(3):883-894.
  • 5Yamazaki T,Yang XO,Chung Y,et al.CCR6 regulates the migration of inflammtory and regulatory T cells[J].J Immunol,2008,181(12):8391-8401.
  • 6Francis JN,Sabroe I,Lloyd CM,et al.Elevated CCR6+CD4+T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response[J].Clin Exp Immunol,2008,152(3):440-447.
  • 7He S,Cao Q,Yoneyama H,et al.MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood[J].J Leukoc Biol,2008,84(6):1549-1556.
  • 8Li H,Chehade M,Liu W,et al.Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells[J].Gastroenterology,2007,133(6):1905-1915.
  • 9Wang C,Kang SG,Lee J,et al.The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut[J].Mucosal Immunol,2009,2(2):173-183.
  • 10Yoshida A,Isomoto H,Hisatsune J,et al.Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis[J].Clin Immunol,2009,130(3):290-297.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部